3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
20
Neoplasms
17
Lung Neoplasms
11
Carcinoma, Non-Small-Cell Lung
9
Uterine Cervical Neoplasms
5
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Colorectal Neoplasms
5
Brain Neoplasms
5
Ovarian Neoplasms
4
Myelodysplastic Syndromes
4
Melanoma
4
Leukemia, Myeloid, Acute
4
Carcinoma, Hepatocellular
4
Triple Negative Breast Neoplasms
3
Skin Neoplasms
3
Neoplasm Metastasis
3
Kidney Neoplasms
3
Carcinoma, Renal Cell
3
Uveal Melanoma
2
Recurrence
2
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell
2
Lymphoma
2
Lung Diseases
2
Hodgkin Disease
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Interventions
pembrolizumab
2
durvalumab
2
Tretinoin
2
Paclitaxel
2
Oxaliplatin
2
Irinotecan
2
Chemoradiotherapy
2
Carboplatin
2
Capecitabine
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
tislelizumab
1
tegafur-gimeracil-oteracil
1
talazoparib
1
sarilumab
1
relugolix
1
pexidartinib
1
pertuzumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
enzalutamide
1
dostarlimab
1
cemiplimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Blood Specimen Collection
×
90 days
×
Clear all
No trials found.